Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1142 | 2729 | 30.3 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
170 | 21413 | HEAD AND NECK CANCER//LARYNGECTOMY//HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEAD AND NECK CANCER | Author keyword | 68 | 11% | 22% | 606 |
2 | INDUCTION CHEMOTHERAPY | Author keyword | 51 | 30% | 5% | 142 |
3 | LOCALLY ADVANCED HEAD AND NECK CANCER | Author keyword | 30 | 79% | 1% | 19 |
4 | LARYNX PRESERVATION | Author keyword | 22 | 46% | 1% | 35 |
5 | ALTERED FRACTIONATION | Author keyword | 20 | 49% | 1% | 29 |
6 | ADVANCED HEAD AND NECK CANCER | Author keyword | 16 | 54% | 1% | 20 |
7 | HEAD AND NECK CARCINOMA | Author keyword | 14 | 19% | 2% | 64 |
8 | ACCELERATED FRACTIONATION | Author keyword | 12 | 37% | 1% | 27 |
9 | ACCELERATED RADIOTHERAPY | Author keyword | 11 | 30% | 1% | 30 |
10 | ORGAN PRESERVATION | Author keyword | 8 | 12% | 2% | 62 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LOCALLY ADVANCED HEAD | 246 | 40% | 17% | 475 |
2 | ADVANCED RESECTABLE HEAD | 86 | 84% | 2% | 47 |
3 | STAGE OROPHARYNX CARCINOMA | 71 | 63% | 3% | 72 |
4 | ADVANCED LARYNGEAL CANCER | 69 | 41% | 5% | 131 |
5 | CONCOMITANT CHEMOTHERAPY | 59 | 47% | 3% | 92 |
6 | INDUCTION CHEMOTHERAPY | 55 | 16% | 12% | 320 |
7 | ADVANCED HEAD | 53 | 22% | 8% | 215 |
8 | FLUOROURACIL INDUCTION CHEMOTHERAPY | 49 | 94% | 1% | 17 |
9 | UNRESECTABLE HEAD | 48 | 70% | 1% | 40 |
10 | ACTIVE DRUG | 42 | 58% | 2% | 49 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Head and neck cancer | 2008 | 421 | 133 | 36% |
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials | 1996 | 266 | 54 | 91% |
Medical progress - Head and neck cancer | 2001 | 735 | 102 | 28% |
Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: A systematic review and meta-analysis of published studies | 2014 | 5 | 17 | 76% |
MEDICAL PROGRESS - HEAD AND NECK-CANCER | 1993 | 1137 | 110 | 34% |
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis | 2001 | 160 | 41 | 90% |
State-of-the-art management of locally advanced head and neck cancer | 2005 | 105 | 43 | 65% |
State-of-the-Art and Emerging Treatment Options in the Management of Head and Neck Cancer: News from 2013 | 2014 | 5 | 77 | 60% |
Head and Neck Cancers | 2011 | 48 | 164 | 35% |
Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: A meta-analysis | 2012 | 12 | 41 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEAD NECK ONCOL PROGRAM | 5 | 23% | 0.7% | 20 |
2 | CLIN ONCOL RADIOTHER IE | 4 | 42% | 0.3% | 8 |
3 | AMBULANZZENTRUM BEREICH STRAHLENTHER IE | 4 | 75% | 0.1% | 3 |
4 | MED ONCOL INTERNAL MED SCI | 4 | 75% | 0.1% | 3 |
5 | LUDWIG BOLTZMANN GEROSTOMATOL | 3 | 100% | 0.1% | 3 |
6 | CANCEROL CERVICO IALE | 3 | 30% | 0.3% | 7 |
7 | METHODS DIFFERENTIAL PSYCHOL | 2 | 67% | 0.1% | 2 |
8 | HALL EDWARDS RADIOTHER Y GRP | 2 | 24% | 0.2% | 6 |
9 | BONE MARROW TRANSPLANTAT MED ONCOL HEMATOL | 1 | 100% | 0.1% | 2 |
10 | CLIN POLICLIN HAEMATOL ONCOL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179536 | TRANSORAL ROBOTIC SURGERY//TORS//REIRRADIATION |
2 | 0.0000167689 | PALLIATION PALLIATIVE CARE//SURVIVING RELATIVES//DISEASE SURVIVAL |
3 | 0.0000141785 | PLANNED NECK DISSECTION//NECK MANAGEMENT//NECK DISSECTION |
4 | 0.0000137737 | FRACTIONATED X IRRADIATION//RAT YOLK SAC TUMOR//DRUG EFFECT ON BRAIN |
5 | 0.0000125638 | GLOTTIC CANCER//SUPRACRICOID LARYNGECTOMY//GLOTTIC CARCINOMA |
6 | 0.0000106077 | UW QOL//REG MAXILLO IAL UNIT//EORTC QLQ HN35 |
7 | 0.0000099395 | NIMOTUZUMAB//H R3//CETUXIMAB |
8 | 0.0000098068 | ELECTIVE NECK DISSECTION//NECK DISSECTION//SELECTIVE NECK DISSECTION |
9 | 0.0000087029 | TCD50//REPOPULATION//R1H RHABDOMYOSARCOMA |
10 | 0.0000072528 | RADIATION MYELOPATHY//LINEAR QUADRATIC MODEL//EXPT ZENTRUM |